Morgan Stanley's decision to maintain an Equal-Weight rating on RH indicates a neutral outlook for the stock. However, the lowered price target from $275 to $260 suggests a slightly less optimistic view on the stock's potential upside. This news may not have a significant short-term impact on the stock price, but it could influence investor sentiment.